Phreesia (PHR) Projected to Post Earnings on Wednesday

Phreesia (NYSE:PHR - Get Free Report) is expected to post its Q1 2026 quarterly earnings results before the market opens on Wednesday, May 28th. Analysts expect Phreesia to post earnings of ($0.13) per share and revenue of $115.00 million for the quarter.

Phreesia Trading Up 0.2%

NYSE PHR opened at $25.45 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The firm's fifty day moving average price is $25.32 and its 200 day moving average price is $25.08. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of -17.31 and a beta of 0.74. Phreesia has a 12 month low of $17.07 and a 12 month high of $30.53.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent analyst reports. Needham & Company LLC reaffirmed a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research report on Thursday, March 13th. KeyCorp lowered their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Piper Sandler reissued an "overweight" rating and set a $33.00 price objective (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group raised their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, March 13th. Finally, DA Davidson lowered their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Phreesia has an average rating of "Buy" and a consensus target price of $31.33.

Insiders Place Their Bets

In related news, SVP David Linetsky sold 4,499 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the sale, the senior vice president now directly owns 217,239 shares in the company, valued at approximately $5,155,081.47. The trade was a 2.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Evan Roberts sold 1,845 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $23.81, for a total transaction of $43,929.45. Following the sale, the chief operating officer now owns 774,807 shares of the company's stock, valued at approximately $18,448,154.67. This represents a 0.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 42,474 shares of company stock worth $1,023,208. Insiders own 5.80% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Caxton Associates LLP acquired a new stake in Phreesia in the first quarter valued at $316,000. NewEdge Advisors LLC increased its holdings in shares of Phreesia by 262.7% in the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after acquiring an additional 11,181 shares during the period. Royal Bank of Canada increased its holdings in shares of Phreesia by 208.8% in the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock worth $617,000 after acquiring an additional 16,309 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock valued at $1,599,000 after buying an additional 2,158 shares in the last quarter. Finally, AQR Capital Management LLC grew its position in Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock valued at $4,090,000 after buying an additional 132,015 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.